Services

31. Druggability 5/30/2024

    To offer comprehensive solutions to Mycenax’s customers, we provide one-stop shop services including cell line development, upstream cell culture process development, downstream purification process development, formulation development, analytical method development, process scale-up study, PIC/S GMP production and aseptic fill and finish.

32. Virotherapy Manufacturing 5/15/2024

    Seamlessly delivering your virotherapy

    With industry-leading viral expertise, Recipharm Advanced Bio navigates the rapidly evolving field of virotherapy to support the development and manufacturing of your gene therapies, viral vector vaccines and oncolytic viruses (OVs).

33. RNA Therapies 5/15/2024

    One Team, One Roof, One CDMO

    Recipharm Advanced Bio's expanded biologics services and technologies encompass the entire RNA development and manufacturing value chain, helping to deliver your innovation to patients seamlessly.

34. Biologics Manufacturing 5/15/2024

    Recipharm Advanced Bio GMP manufacturing units focus on process robustness and consistency to ensure product quality, purity and efficacy. Our multi-product manufacturing facilities feature state-of-the-art equipment for animal cell-derived viral and microbial products for your clinical trials in phase 1-2 and in accordance with cGMP guidelines.

35. Scale Your Vaccine With Path-To-PAD 3/1/2024

    The COVID-19 pandemic highlighted the urgent need for a quick, efficient, and scalable vaccine production process. Resilience's Vaccine Path-To-PAD (Process and Analytical Development) program provides a clear and easy path to maximize yields at the beginning of development, with deep expertise in vaccines, robust expression platforms, and high-quality Vero and Quail cell lines.

36. Process Development 1/25/2024

    EirGenix is a contract development and manufacturing organization that performs high quality and cost-effective services supporting our clients in development, analytical testing, and GMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing

    EirGenix has strong process development capabilities in both microbial and mammalian systems to provide our clients process development, process optimization, and process troubleshooting. We have successfully delivered results to meet clients’ requirement in product productivity, product quality, and process cost effectiveness. Our previous project experience includes recombinant proteins, plasmid DNA, fusion proteins, monoclonal antibodies, and biosimilars.

37. cGMP Manufacturing - Mammalian System 1/25/2024

    Review how a comprehensive cGMP manufacturing facility is poised to support the development and manufacture of your mammalian cell program.

38. Cell Line Development 1/25/2024

    EirGenix provides comprehensive cell line development services from DNA replication to the generation of stable producer cell lines for further process development and manufacturing. Our goal is to assist our clients in identifying the most favorable cell line expression system and provide optimization to achieve or surpass expected project targets.

39. Antibody-Drug Conjugate 1/25/2024

    EirGenix provides client-oriented contract development and manufacturing services for biologics, especially monoclonal antibodies and biosimilars. Combining the capabilities of EirGenix’s strategic partner, Formosa Laboratories, Inc, a high potency API manufacturer, we offer integrated services for Antibody Drug Conjugate (ADC) development and manufacturing.

40. cGMP Manufacturing - Microbial System 1/25/2024

    Learn how our 4,000-square-foot cGMP manufacturing site is purpose-built to support your microbial program from pre-clinical to commercial manufacturing.